To study immune-based mechanisms of long-term sustained synergy in in vivo models of breast cancer, we conducted immunophenotyping of IL-2, IFN-gamma, and THBS-4 in treated tumors with cytokine and Nanostring transcriptomic analysis. This evidence concerns the gene IL2 and breast carcinoma.